At Tropic Biosciences, They develop high-performing commercial varieties of tropical crops which promote grower wellbeing, consumer health, and improved sustainable environmental practices, using cutting edge non-GMO gene editing techniques.

Regeneron Pharmaceuticals is a biopharmaceutical company that discovers, develops, and commercializes pharmaceutical products for the treatment of serious medical conditions. The Company has therapeutic candidates in clinical trials for the potential treatment of cancer, eye diseases, and inflammatory diseases, and has preclinical programs in other diseases and disorders. The company’s product portfolio includes EYLEA, an aflibercept injection; ARCALYST, a rilonacept Injection for subcutaneous use; ZALTRAP for metastatic colorectal cancer; trap fusion proteins; and fully human monoclonal antibodies. On March 26, 2012, it was announced that Sanofi and Regeneron are in development with a new cholesterol drug which will help reduce cholesterol up to 72%. Regeneron Pharmaceuticals was founded in 1988 and is currently headquartered in New York, USA.

Guangdong Sanjie Forage Biotechnology Co., Ltd., established on 2017-07-18, Business scope includes seed wholesale;feed processing;Agricultural Science Research and Experimental Development;Commodity wholesale trade(Except for licensed and approved products);Technology Import and Export;horticultural crops planting;Agricultural Machinery Wholesale;trade agent;Trade Advisory Services;Agricultural Technology Development Services;Agricultural Technology Consulting,communication service;Agricultural technology transfer service;Science and Technology Information Consulting Services;flower planting;Planting of other cash crops;Agricultural Machinery Service;Primary processing service of agricultural products;Forest Products Primary Processing Services;Commodity retail trade(Except for licensed and approved products);Import and export(Excluding franchised products);Investment Advisory Services;Agricultural technology extension service;Agricultural project development;Processing of plant extract raw materials(Does not include licensed operations,Projects prohibited by laws and regulations shall not be operated);Investment(Does not include licensed operations,Projects prohibited by laws and regulations shall not be operated);

Q Therapeutics is a development stage company, engages in the development of human cell-based therapies for the treatment of degenerative diseases of the brain and spinal cord. The company develops Q-Cells that is intended for the treatment of amyotrophic lateral sclerosis, multiple sclerosis, transverse myelitis, traumatic spinal cord injury, and Parkinson’s disease, as well as for Alzheimer’s disease, traumatic brain injury, cerebral palsy, Leukodystrophies and central nervous system storage diseases, and peripheral neuropathies. Q Therapeutics is headquartered in Salt Lake City, Utah.

Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines to treat patients with serious or life-threatening medical conditions. It creates multiple products on the market and a development pipeline. The company became a member of the Roche Group in 2009. As part of their merger agreement, Roche and Genentech combined their pharmaceutical operations in the United States. Genentech’s South San Francisco campus now serves as the headquarters for Roche pharmaceutical operations in the United States. Genentech’s Research and Early Development section operates as an independent center within Roche. Genentech was founded in 1976 by [Robert Swanson](https://www.crunchbase.com/person/robert-a-swanson) and [Herbert Boyer](https://www.crunchbase.com/person/herbert-w-boyer). It is headquartered in South San Francisco, C.A.

Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France.

Courtagen Life Sciences, Inc. provides proteomic and genomic products and services to the life sciences industry. It offers clinical genetic tests for developmental delay, intellectual disability, autism spectrum disorders, epilepsy and seizure disorders and mitochondrial disorders. The company was founded by Jocelyn W. Burke, Elizabeth Holland, Brendan L. McKernan, Kevin J. McKernan, Brian R. McKernan and Timothy Olcott in 1999 and is headquartered in Woburn, MA.

Assistance Publique des Hôpitaux de Paris SA the company is headquartered in Paris, France.

Sarco Oy provides integrated light solutions. It offers alarms, communication systems, special electronic devices, and vehicle warning lights and systems. The company was founded in 1926 and is headquartered in Helsinki, Finland.

Suzhou Qihe Biotechnology Co., Ltd., established on 2021-09-15, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Natural science research and experimental development;Medical Research and Experimental Development;Agricultural Science Research and Experimental Development;Engineering and Technology Research and Experimental Development;R&D and application of cell technology;Chemical product sales(No licensed chemical products);Experimental analysis instrument sales;Instrument sales;Information Consulting Service(Not including licensing information consulting services);Information Technology Consulting Services;software development(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

UCLB is the commercialisation company of UCL and its partner NHS Trusts. They bring to market truly world-leading, world-changing technologies, innovations that have a real and positive impact on people’s lives. UCLB the access point to the wealth of innovation and intellectual property emanating from UCL and partner hospitals including University College Hospital, Great Ormond Street Hospital, Royal Free Hospital and Moorfields Eye Hospital. They offer a number of services to assist the technology development process, from consultancy through to collaborative research, IP licensing and the creation of spinout companies and joint ventures to maximise the commercial potential of new discoveries, materials and processes.

CAVΛDIS™ is a Dutch biomedical company active in the field of cardiovascular risk assessment. They develop prognostic tests to identify patients at risk of cardiovascular and disease. The company identified several novel biomarkers predictive for cardiovascular events. It is their goal is to develop clinically meaningful risk stratification tools that will help personalize treatment and achieve better patient outcomes.

Arista Cereal Technologies Pty Ltd. is an Australian private company located in New South Wales. The firm develops and commercializes wheat.\nThe company says this about itself: ARISTA is a privately held, joint venture company formed by Limagrain, a fifty-year-old farmer-founded and directed, world player in wheat seeds, and Commonwealth Scientific and Industrial Research Organisation (CSIRO), Australia's national research agency for nearly 100 years, a globally recognized organization focused on using science to make a positive difference in the world. The companies began collaborating in fundamental research in wheat starch more than 20 years ago and joined their efforts and expertise in 2006 to develop and commercialize wheat with direct consumer health benefits.

River Diagnostics BV develops and manufactures medical devices and equipment. The company's products include the instruments for spectroscopic analysis of cells and tissues, as well as the control software RiverICon, and the data analysis software SkinTools. River Diagnostics was founded by William Riggs, Gerwin J. Puppels, and Eric Marple in 2002 and is headquartered in Rotterdam, the Netherlands.

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

Roche Diagnostics GmbH, part of Roche Holding AG, is a company headquartered in Mannheim, Germany, involved in laboratory analytical instruments. Andreas Schmitz and Claus Haberda are the current co-CEOs of the firm. On January 01, 1999 Roche Holding AG acquired Roche Diagnostics GmbH.